Bristol-Myers Squibb

Why 2015 is the year of the biopharma blockbuster—with charts
BioPharma Dive
Tue, 03/24/15 - 10:29 am
biotech
Opdivo
Praluent
LCZ696
Ibrance
Viekira Pak
evolocumab
Gardasil 9
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
Vertex Pharmaceuticals
Merck
Amgen
AbbVie
Astellas
3 Big Pharma Stocks Wall Street Is Wrong About
Motley Fool
Mon, 03/23/15 - 12:06 pm
Bristol-Myers Squibb
Pfizer
Eli Lilly
AstraZeneca Lags in Cancer Race
Yahoo/Bloomberg
Fri, 03/20/15 - 08:22 am
AstraZeneca
MEDI4736
Bristol-Myers Squibb
AZD9291
Bristol-Myers chief's last 'paycheck' as CEO is a doozy at $27M
Fierce Pharma
Thu, 03/19/15 - 08:01 am
Bristol-Myers Squibb
executive pay
Lamberto Andreotti
A Decade Old Drug Launch In China With Important Insights Today
Forbes
Wed, 03/18/15 - 10:53 am
China
Baraclude
hepatitis B
Bristol-Myers Squibb
FDA to review re-submitted Bristol-Myers hepatitis C drug
Yahoo/Reuters
Thu, 03/12/15 - 09:44 pm
FDA
Bristol-Myers Squibb
daclatasvir
hepatitis C
New Bristol-Myers CEO on tap for $8.7M-plus pay package
Fierce Pharma
Tue, 03/10/15 - 09:43 am
Bristol-Myers Squibb
executive pay
Giovanni Caforio
Pharma CEOs
Opdivo's survival benefit inspired FDA to act fast on NSCLC approval: Pazdur
Fierce Pharma
Mon, 03/9/15 - 02:52 pm
FDA
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
Bristol-Myers' cancer meds are $15B bait for a big, deal-hungry buyer
Fierce Pharma
Mon, 03/9/15 - 12:05 pm
Bristol-Myers Squibb
M&A
Opdivo
Bristol-Myers Lung Cancer Drug Opdivo Wins Speedy OK
Investors.com
Wed, 03/4/15 - 05:56 pm
Opdivo
Bristol-Myers Squibb
FDA
lung cancer
cancer immunotherapy
Bristol-Myers forges a billion-dollar cancer vaccine deal with Bavarian Nordic
Fierce Biotech
Wed, 03/4/15 - 08:34 am
Bavarian Nordic
Bristol-Myers Squibb
vaccines
prostate cancer
FDA Accepts Bristol-Myers Squibb Co Supplemental Yervoy BLA For Melanoma
Bidness Etc.
Tue, 03/3/15 - 08:32 am
FDA
Yervoy
Bristol-Myers Squibb
melanoma
Only The Paranoid Biotechs Will Survive
Forbes
Mon, 03/2/15 - 04:42 pm
biotech
Bristol-Myers Squibb
Flexus
Bristol-Myers takes a big step in its PD-1 lung cancer race with Merck
Fierce Biotech
Mon, 03/2/15 - 12:38 pm
Merck
Bristol-Myers Squibb
lung cancer
anti-PD-1 immunotherapy
Opdivo
Keytruda
Which Cancer Immunotherapy Will Be the Most Successful?
Motley Fool
Sat, 02/28/15 - 12:50 pm
cancer immunotherapy
Opdivo
Bristol-Myers Squibb
Merck
Keytruda
anti-PD-1 immunotherapy
Bristol hep C drug helps cure 97 pct of HIV coinfected patients-study
Yahoo/Reuters
Thu, 02/26/15 - 04:46 pm
Bristol-Myers Squibb
hepatitis C
HIV
daclatasvir
Rigel Pharma CEO pulls back the curtain on drug deal with Bristol-Myers
Bizjournals.com
Thu, 02/26/15 - 03:04 pm
Rigel Pharmaceuticals
Bristol-Myers Squibb
Gilead's hep C star Harvoni, BMS' cancer med Opdivo lead ranks of 'exciting' launches
Fierce Pharma Marketing
Thu, 02/26/15 - 10:23 am
Gilead Sciences
Harvoni
hepatitis C
Bristol-Myers Squibb
Opdivo
melanoma
lung cancer
Global cancer drug market to grow to $111 billion by 2020: report
Medical Marketing and Media
Tue, 02/24/15 - 05:02 pm
cancer
cancer immunotherapy
Merck
Bristol-Myers Squibb
PD-1 inhibitors
Bristol-Myers bags IDO immunotherapy in $1.25B buyout of fledgling Flexus
Fierce Biotech
Mon, 02/23/15 - 09:40 am
Bristol-Myers Squibb
IDO immunotherapy
cancer immunotherapy
Flexus
M&A

Pages